A Decade of Invasive Meningococcal Disease Surveillance in Poland

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Skoczyńska, Anna ^a   Waśko, Izabela ^a   Kuch, Alicja ^a   Kadłubowski, Marcin ^a,b   Gołebiewska, Agnieszka ^a   Foryś, Małgorzata ^a,c   Markowska, Marlena ^a   Ronkiewicz, Patrycja ^a   Wasiak, Katarzyna ^a   Kozińska, Aleksandra ^a   Matynia, Bozena ^a   Hryniewicz, Waleria ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b AM Solutions ^*  (Poland)

^c UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; PENICILLIN DERIVATIVE; PORIN A; PROTEIN FETA; RIFAMPICIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEMALE; FETA GENE; GENE SEQUENCE; HUMAN; INCIDENCE; INFANT; INFECTION SENSITIVITY; INVASIVE MENINGOCOCCAL DISEASE; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MORTALITY; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; POLAND; POLYMERASE CHAIN REACTION; PORA GENE; PRESCHOOL CHILD; SCHOOL CHILD; SEQUENCE ANALYSIS; STRAIN DIFFERENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, MENINGOCOCCAL; MIDDLE AGED; MORTALITY; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; POLAND; YOUNG ADULT;

EID: 84882734145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071943     Document Type: Article

References (58)

1. Stephens DS, (2007) Conquering the meningococcus. FEMS Microbiol Rev 31: 3-14.
2. Khatami A, Pollard AJ, (2010) The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines 9: 285-298.
3. Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, et al. (2010) Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 50: 184-191.
4. Healy CM, Butler KM, Smith EO, Hensey OP, Bate T, et al. (2002) Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000. Clin Infect Dis 34: 1323-1330.
5. Skoczynska A, Kadlubowski M, Knap J, Szulc M, Janusz-Jurczyk M, et al. (2006) Invasive meningococcal disease associated with very high case fatality rate in the North-West of Poland. FEMS Immunol Med Microbiol 46: 230-235.
6. Pollard AJ, Nadel S. (2006) Course of disease and clinical management. In: Frosh M, Maiden MCJ, editors. Handbook of Meningococcal Disease. Weinheim: Wiley-VCH. Pp. 481-517.
7. Edwards MS, Baker CJ, (1981) Complications and sequelae of meningococcal infections in children. Journal Pediatr 99: 540-545.
8. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM, (2001) Meningococcal disease. New Engl J Med 344: 1378-1388.
9. Harrison LH, Pass MA, Mendelsohn AB, Egri M, Rosenstein NE, et al. (2001) Invasive meningococcal disease in adolescents and young adults. JAMA 286: 694-699.
10. Harrison LH, Trotter CL, Ramsay ME, (2009) Global epidemiology of meningococcal disease. Vaccine 27supp. 2: B51-B63.
11. The European Commission of the European Communities, European Union website (2000) Commission decision of 22 December 1999 on the communicable diseases to be progressively covered by the community network under decision number 2119/98/EC of the Parliament and of the Council. Official J Eur Communities L28/50. Available: http://europa.eu.int/eur-lex/pri/en/oj/d?at/2000/l_028/l_02820000203en00500053.pdf. Accessed 2013 May 24.
12. The European Parliament, the Council of the EU, European Union website (1998) Decision number 2119/98/EC of the European Parliament and of the Council of 24 September 1998: setting up a network for the epidemiological surveillance and control of communicable diseases in the community: Official J Eur Communities L268/1. Available: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31998D2119:EN:NOT. Accessed 2013 May 24.
13. Guiver M, Borrow R, Marsh J, Gray SJ, Kaczmarski EB, et al. (2000) Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol Med Microbiol 28: 173-179.
14. Taha MK, (2000) Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 38: 855-857.
15. Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement; Wayne, PA M100-S21.
16. The European Committee on Antimicrobial Susceptibility Testing (2013) Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1, 2013. http://www.eucast.org.
17. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95: 3140-3145.
18. Jolley KA, Brehony C, Maiden MC, (2007) Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol Rev 31: 89-96.
19. Skoczyńska A, Wasko I, Kuch A, Gołe{ogonek}biewska A, Foryś M, et al. (2010) Outbreak of invasive meningococcal disease in Goleniów County, north-west Poland, March 2009. Euro Surveill 15(34): pii = 19646. Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19646. Accessed 2013 May 24.
20. Kadłubowski M, Waśko I, Klarowicz A, Hryniewicz W (2007) Invasive meningococcal disease at a military base in Warsaw, January 2007. Euro Surveill 12: pii = 3147. Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3147. Accessed 2013 April 24.
21. Posmyk U, Hryniewicz W, Skoczyńska A, Kumala R, (2012) Invasive meningococcal disease in Opolskie Voivodeship between 2005-2010. Polski Merkuriusz Lekarski 32: 287-292.
22. Grecki M, Bienias M (2006) Outbreak of invasive meningococcal disease among soldiers in Skwierzyna, Poland, March 2006. Euro Surveill 2006;11(7): E060706.4. Available from: http://www.eurosurveillance.org/ew/2006/060706.asp#4. Accessed 2013 April 24.
23. Vogel U, Claus H, (2003) Molecular epidemiology of Neisseria meningitidis. Front Biosci 8: 14-22.
24. Gryniewicz O, Kolbusz J, Rosinska M, Zielinski A, Stefanoff P (2007) Epidemiology of meningococcal meningitis and changes in the surveillance system in Poland, 1970-2006. Euro Surveill 12(5). Available: http://www. eurosurveillance.org/em/v12n05/1205-224.asp. Accessed 2013 April 24.
25. Kaczmarski EB, Ragunathan PL, Marsh J, Gray SJ, Guiver M, (1998) Creating a national service for the diagnosis of meningococcal disease by polymerase chain reaction. Commun Dis Public Health 1: 54-56.
26. Papavasileiou K, Papavasileiou E, Tzanakaki G, Voyatzi A, Kremastinou J, et al. (2011) Acute bacterial meningitis cases diagnosed by culture and PCR in a children's hospital throughout a 9-Year period (2000-2008) in Athens, Greece. Mol Diagn Ther 15: 109-13.
27. Skoczyńska A, Sadowy E, Bojarska K, Strzelecki J, Kuch A, et al. (2011) The current status of invasive pneumococcal disease in Poland. Vaccine 29: 2199-2205.
28. Skoczyńska A, Hryniewicz W, Ronkiewicz P, Kuch A, (2012) BINet - surveillance network for community-acquired invasive bacterial infections (in Polish). Standardy Medyczne/Pediatria 9: 389-395.
29. European Centre for Disease Prevention and Control (2011) Annual Epidemiological Report 2011. Reporting on 2009 surveillance data and 2010 epidemic intelligence data. Stockholm: ECDC: 155-157.
30. Skoczyńska A, Kuch A, Waśko I, Gołe{ogonek}biewska A, Ronkiewicz P, et al. (2012) Invasive meningococcal disease in patients under 20 years of age in Poland, 2009-2011. Pediatria Polska 87: 438-443.
31. Konior R, Jackowska T, Skoczyńska A, Hryniewicz W, Kajfasz P, et al. (2012) Vaccination against meningococci - current recommendations and suggestions (in Polish). Pediatria Polska 87: 489-497.
32. Kriz P, Wieffer H, Holl K, Rosenlund M, Budhia S, et al. (2011) Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century. Expert Rev Vaccines 10: 1477-1486.
33. Racloz VN, Luiz SJD (2010) The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology. BMC Infect Dis 10: 175. Available: http://www.biomedcentral.com/1471-2334/10/175. Accessed 2013 April 24.
34. Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, et al. (2007) A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev 31: 27-36.
35. EU-IBIS Network (2006) Invasive Neisseria meningitidis in Europe 2006. Health Protection Agency, London. Available: http://www.hpa-bioinformatics.org.uk/euibis/documents/2006_meningo.pdf. Accessed 2013 April 24.
36. Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, et al. (1999) The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 180: 1894-1901.
37. Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, et al. (2012) Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg Infect Dis 18: 63-70.
38. Bröker M, Jacobsson S, Kuusi M, Pace D, Simões MJ, et al. (2012) Meningococcal serogroup Y emergence in Europe: Update 2011. Hum Vaccin Immunother 8: 1907-11.
39. Trotter CL, Fox AJ, Ramsay ME, Sadler F, Gray SJ, et al. (2002) Fatal outcome from meningococcal disease- an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J Med Microbiol 51: 855-860.
40. Skoczyńska A, Kriz P, Konradsen H, Hryniewicz W, (2000) Characteristics of the major etiologic agents of bacterial meningitis isolated in Poland in 1997-98. Microb Drug Resist 2: 147-153.
41. Taha MK, Vazquez JA, Hong E, Bennett DE, Bertrand S, et al. (2007) Target gene sequencing to characterize penicillin G susceptibility of Neisseria meningitidis. Antimicrob Agents Chemother 51: 2784-2792.
42. Taha MK, Thulin Hedberg S, Szatanik M, Hong E, Ruckly C, et al. (2010) Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing. Antimicrob Agents Chemother 54: 3651-3658.
43. Caugant DA, Froholm LO, Bovre K, Holten E, Frasch CE, et al. (1986) Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci USA 83: 4927-4931.
44. Diermayer M, Hedberg K, Hoesly F, Fischer M, Perkins B, et al. (1999) Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain. JAMA 281: 1493-1497.
45. Rouaud P, Perrocheau A, Taha MK, Sesboué C, Forgues AM, et al. (2006) Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005. Euro Surveill 11: 178-181. Available: http://www.eurosurveillance.org/images/dynamic/EQ/v06n03/v06n03.pdf. Accessed 2013 April 24.
46. Alcalá B, Arreaza L, Salcedo C, Uría MJ, De La Fuente L, et al. (2002) Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain. Emerg Infect Dis 8: 1512-1514.
47. Caniça M, Dias R, Ferreira E, (2004) Meningococci Study Group (2004) Neisseria meningitidis C:2b:P1.2,5 with intermediate resistance to penicillin, Portugal. Emerg Infect Dis 10: 526-529.
48. Stefanelli P, Fazio C, Neri A, Tonino S, Mastrantonio P, (2004) Emergence in Italy of a Neisseria meningitidis clone with decreased susceptibility to penicillin. Antimicrob Agents Chemother 48: 3103-3106.
49. Skoczyńska A, Kadłubowski M, Wasko I, Hryniewicz W, (2006) Characterisation of Neisseria meningitidis C:2b:P1.2,5 isolates in Poland. Clin Microbiol Infect 12: 1027-1030.
50. Neri A, Fazio C, Carannante A, Mastrantonio P, Stefanelli P, (2012) Diversity of Neisseria meningitidis invasive isolates in Italy in the period 2008-2010. J Prev Med Hyg 53: 109-112.
51. Iser BP, Lima HC, de Moraes C, de Almeida RP, Watanabe LT, et al. (2012) Outbreak of Neisseria meningitidis C in workers at a large food-processing plant in Brazil: challenges of controlling disease spread to the larger community. Epidemiol Infect 140: 906-915.
52. de Lemos AP, Yara TY, Gorla MC, de Paiva MV, de Souza AL, et al. (2007) Clonal distribution of invasive Neisseria meningitidis serogroup C strains circulating from 1976 to 2005 in greater Sao Paulo, Brazil. J Clin Microbiol 45: 1266-1273.
53. Whalen CM, Hockin JC, Ryan A, Ashton F, (1995) The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA 273: 390-394.
54. Jelfs J, Munro R, Ashton FE, Caugant DA, (2000) Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol Infect 125: 285-298.
55. Harrison LH, Jolley KA, Shutt KA, Marsh JW, O'Leary M, et al. (2006) Antigenic shift and increased incidence of meningococcal disease. J Infect Dis 193: 1266-1274.
56. Krizova P, Musilek M, (1995) Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37. Cent Eur J Public Health 3: 189-194.
57. Tyrrell GJ, Chui L, Johnson M, Chang N, Rennie RP, et al. (2002) Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada. Emerg Infect Dis 8: 519-521.
58. McGuinness BT, Clarke IN, Lambden PR, Barlow AK, Poolman JT, et al. (1991) Point mutation in meningococcal por A gene associated with increased endemic disease. Lancet 337: 514-517.